Genus PLC (LON:GNS)
2,158p+1.22%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Disease-resistant pig approval and surging pig royalties drive a genuine profit recovery; valuation remains demanding.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Genus PLC
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It of…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £1.4B
Recent dividends
- 5 Mar 202611.20p
- 6 Nov 202521.70p
- 6 Mar 202510.30p
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Genus PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free